April 1, 2010 Novo Nordisk and ChromaCon jointly present results of MCSGP study
Zurich. Novo Nordisk A/S and ChromaCon Ltd. will jointly present the results of the preparative RP-purification of insulin with the MCSGP-technology at the RECOVERY-2010 conference as oral contribution.